Deal Watch: U.S. Pharmas Look To Europe For Partners
Pfizer gained an option to acquire Dutch biopharma AM-Pharma, while Lilly hooked up with Germany’s BioNTech in a cancer immunotherapy pact. Juno acquired German biotech Stage Cell Therapeutics.
Pfizer gained an option to acquire Dutch biopharma AM-Pharma, while Lilly hooked up with Germany’s BioNTech in a cancer immunotherapy pact. Juno acquired German biotech Stage Cell Therapeutics.